No abstract available
Plain language summary
This secondary analysis of a randomized clinical trial examines changes in the progression of progressive supranuclear palsy (PSP) associated with 31 concomitant medication classes used by study participants over 1 year.
Publication types
-
Randomized Controlled Trial
MeSH terms
-
Diagnosis, Differential
-
Disease Progression
-
Humans
-
Supranuclear Palsy, Progressive* / diagnosis
-
Supranuclear Palsy, Progressive* / drug therapy